Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson, Lena E. Friberg
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	Wiley 2023-01-01
श्रृंखला:	Clinical and Translational Science
ऑनलाइन पहुंच:	https://doi.org/10.1111/cts.13423

समान संसाधन

Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
द्वारा: Maddalena Centanni, और अन्य
प्रकाशित: (2020-03-01)

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
द्वारा: Eman I. K. Ibrahim, और अन्य
प्रकाशित: (2023-09-01)

Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
द्वारा: Sarah Waliany, MD, MS, और अन्य
प्रकाशित: (2019-09-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
द्वारा: Maria Dimou, और अन्य
प्रकाशित: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
द्वारा: Elisabetta Abruzzese, और अन्य
प्रकाशित: (2014-04-01)

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
द्वारा: Nick Verougstraete, और अन्य
प्रकाशित: (2022-03-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
द्वारा: Evan Pisick, और अन्य
प्रकाशित: (2004-01-01)

Inhibition of c-Kit by tyrosine kinase inhibitors
द्वारा: Allison Galanis, और अन्य
प्रकाशित: (2015-03-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
द्वारा: G. V. Lukina, और अन्य
प्रकाशित: (2015-12-01)

Tyrosine Kinase Inhibitors Target B Lymphocytes
द्वारा: Nikki Lyn Esnardo Upfold, और अन्य
प्रकाशित: (2023-02-01)

Spheroacanthocytes secondary to novel tyrosine kinase inhibitors
द्वारा: Michael Ashby, और अन्य
प्रकाशित: (2020-11-01)

Second-generation inhibitors of Bruton tyrosine kinase
द्वारा: Jingjing Wu, और अन्य
प्रकाशित: (2016-09-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
द्वारा: Hor-Yue Tan, और अन्य
प्रकाशित: (2018-02-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
द्वारा: Lihua Huang, और अन्य
प्रकाशित: (2015-09-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
द्वारा: Yi-fan Chen, और अन्य
प्रकाशित: (2011-12-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
द्वारा: John J. Ryan, MD
प्रकाशित: (2016-12-01)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
द्वारा: Yu Yao, और अन्य
प्रकाशित: (2023-01-01)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
द्वारा: Ainun Nizar Masbuchin, और अन्य
प्रकाशित: (2022-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
द्वारा: Xu H, और अन्य
प्रकाशित: (2019-07-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
द्वारा: Huang JT, और अन्य
प्रकाशित: (2022-11-01)

Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors
द्वारा: Zahra Moradpour, और अन्य
प्रकाशित: (2019-01-01)

Advances in MET tyrosine kinase inhibitors in gastric cancer
द्वारा: Yifan Zhang, और अन्य
प्रकाशित: (2024-06-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
द्वारा: Jiangnan Liu, और अन्य
प्रकाशित: (2024-03-01)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
द्वारा: Obada Ababneh, और अन्य
प्रकाशित: (2022-05-01)

Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
द्वारा: Ahmad Assi, और अन्य
प्रकाशित: (2023-12-01)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
द्वारा: Tasia Amelia, और अन्य
प्रकाशित: (2022-01-01)

Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
द्वारा: Sareshma Sudhesh Dev, और अन्य
प्रकाशित: (2023-11-01)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
द्वारा: Chi-Hao Hu, और अन्य
प्रकाशित: (2023-07-01)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
द्वारा: Ashraf El-Dabh, और अन्य
प्रकाशित: (2019-07-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
द्वारा: Qinlian Jiao, और अन्य
प्रकाशित: (2018-02-01)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
द्वारा: Diogo Alpuim Costa, और अन्य
प्रकाशित: (2018-05-01)

Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
द्वारा: Vineet Agrawal, और अन्य
प्रकाशित: (2015-02-01)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
द्वारा: Toshio Fujino, MD, और अन्य
प्रकाशित: (2021-03-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
द्वारा: D. Samuel Metibemu, और अन्य
प्रकाशित: (2019-12-01)

The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
द्वारा: Eliska Ruzickova, और अन्य
प्रकाशित: (2019-10-01)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
द्वारा: Sachin Gupta, और अन्य
प्रकाशित: (2008-10-01)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
द्वारा: Domenico Ribatti
प्रकाशित: (2010-04-01)

A Review on Newer Tyrosine Kinase Inhibitors and their Uses
द्वारा: NITHU M KUMAR, और अन्य
प्रकाशित: (2018-08-01)

Resistant Mechanism and Treatment Strategy of Tyrosine Kinase Inhibitors
द्वारा: Jianbing QIAO, और अन्य
प्रकाशित: (2011-10-01)

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
द्वारा: C. I. Edvard Smith, और अन्य
प्रकाशित: (2021-11-01)